GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Geratherm Medical AG (STU:GME) » Definitions » Beneish M-Score

Geratherm Medical AG (STU:GME) Beneish M-Score : -2.49 (As of May. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Geratherm Medical AG Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.49 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Geratherm Medical AG's Beneish M-Score or its related term are showing as below:

STU:GME' s Beneish M-Score Range Over the Past 10 Years
Min: -2.8   Med: -2.49   Max: -1.99
Current: -2.49

During the past 13 years, the highest Beneish M-Score of Geratherm Medical AG was -1.99. The lowest was -2.80. And the median was -2.49.


Geratherm Medical AG Beneish M-Score Historical Data

The historical data trend for Geratherm Medical AG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geratherm Medical AG Beneish M-Score Chart

Geratherm Medical AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.21 -2.80 -2.33 -2.56 -2.49

Geratherm Medical AG Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -2.49 -

Competitive Comparison of Geratherm Medical AG's Beneish M-Score

For the Medical Devices subindustry, Geratherm Medical AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Geratherm Medical AG's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Geratherm Medical AG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Geratherm Medical AG's Beneish M-Score falls into.



Geratherm Medical AG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Geratherm Medical AG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1+0.528 * 1.0165+0.404 * 0.8414+0.892 * 1.1137+0.115 * 1.2684
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9168+4.679 * -0.045909-0.327 * 0.9284
=-2.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec22) TTM:Last Year (Dec21) TTM:
Total Receivables was €4.01 Mil.
Revenue was €27.44 Mil.
Gross Profit was €17.88 Mil.
Total Current Assets was €23.55 Mil.
Total Assets was €38.38 Mil.
Property, Plant and Equipment(Net PPE) was €9.99 Mil.
Depreciation, Depletion and Amortization(DDA) was €1.48 Mil.
Selling, General, & Admin. Expense(SGA) was €4.97 Mil.
Total Current Liabilities was €2.19 Mil.
Long-Term Debt & Capital Lease Obligation was €9.30 Mil.
Net Income was €1.02 Mil.
Gross Profit was €0.00 Mil.
Cash Flow from Operations was €2.79 Mil.
Total Receivables was €3.27 Mil.
Revenue was €24.64 Mil.
Gross Profit was €16.32 Mil.
Total Current Assets was €18.89 Mil.
Total Assets was €32.56 Mil.
Property, Plant and Equipment(Net PPE) was €8.78 Mil.
Depreciation, Depletion and Amortization(DDA) was €1.72 Mil.
Selling, General, & Admin. Expense(SGA) was €4.86 Mil.
Total Current Liabilities was €2.15 Mil.
Long-Term Debt & Capital Lease Obligation was €8.34 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(4.011 / 27.44) / (3.274 / 24.639)
=0.146173 / 0.132879
=1.1

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(16.321 / 24.639) / (17.881 / 27.44)
=0.662405 / 0.65164
=1.0165

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (23.553 + 9.985) / 38.38) / (1 - (18.893 + 8.784) / 32.559)
=0.126159 / 0.149943
=0.8414

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=27.44 / 24.639
=1.1137

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.715 / (1.715 + 8.784)) / (1.476 / (1.476 + 9.985))
=0.163349 / 0.128785
=1.2684

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(4.966 / 27.44) / (4.864 / 24.639)
=0.180977 / 0.197411
=0.9168

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((9.295 + 2.185) / 38.38) / ((8.338 + 2.152) / 32.559)
=0.299114 / 0.322184
=0.9284

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1.023 - 0 - 2.785) / 38.38
=-0.045909

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Geratherm Medical AG has a M-score of -2.49 suggests that the company is unlikely to be a manipulator.


Geratherm Medical AG Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Geratherm Medical AG's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Geratherm Medical AG (STU:GME) Business Description

Traded in Other Exchanges
Address
Fahrenheitstrasse 1, Geratal, DEU, 99331
Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.

Geratherm Medical AG (STU:GME) Headlines

From GuruFocus

From FOMO to Just Plain Fear

By Jacob Wolinsky 02-07-2022

GameStop Announces Release Date for First Quarter Fiscal 2023 Results

By Business Wire Business Wire 05-30-2023

GameStop Announces Four-for-One Stock Split

By Business Wire Business Wire 07-06-2022

GameStop (GME): A Comprehensive Valuation Analysis

By GuruFocus Research 11-28-2023

GameStop Appoints New Chief Operating Officer

By Business Wire Business Wire 05-16-2022

GameStop Announces Resignation of CFO

By Marketwired 07-27-2023

GameStop Announces Release Date for First Quarter Fiscal 2022 Results

By Business Wire Business Wire 05-23-2022